المؤلفون: Paul Lorigan, Rohit Thakur, Miles C. Andrews, Kate Hogan, Piyushkumar A. Mundra, Richard Marais, Martin G. Cook, Kang Zeng, Louis Boon, Antonia Banyard, Nathalie Dhomen, Matthew Smith, Jennifer A. Wargo, Jonathan Greenall, Elena Galvani, Garry Ashton, A. Mandal, Beth A. Helmink, Pablo Garcia-Martinez, Gabriela Gremel, Christopher P. E. Chester, Sara Valpione

المصدر: Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Galvani, E, Mundra, P A, Valpione, S, Garcia-Martinez, P, Smith, M, Greenall, J, Thakur, R, Helmink, B, Andrews, M C, Boon, L, Chester, C, Gremel, G, Hogan, K, Mandal, A, Zeng, K, Banyard, A, Ashton, G, Cook, M, Lorigan, P, Wargo, J A, Dhomen, N & Marais, R 2020, ' Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma ', Nature Communications, vol. 11, no. 1, pp. 853 . https://doi.org/10.1038/s41467-020-14632-2Test
Nature Communications

مصطلحات موضوعية: 0301 basic medicine, CD4-Positive T-Lymphocytes, medicine.medical_treatment, Science, Cell, Programmed Cell Death 1 Receptor, General Physics and Astronomy, Cancer immunotherapy, CD8-Positive T-Lymphocytes, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, Mice, 0302 clinical medicine, Stroma, Medicine, Animals, Humans, Exome, Cancer models, lcsh:Science, Melanoma, Cell Proliferation, Multidisciplinary, Manchester Cancer Research Centre, business.industry, Cell growth, ResearchInstitutes_Networks_Beacons/mcrc, General Chemistry, Immunotherapy, medicine.disease, Immune checkpoint, 3. Good health, Blockade, Disease Models, Animal, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Cancer research, Female, lcsh:Q, Stromal Cells, business, Cell Division

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556e5bce3c32f9fe3828bc8a54567eafTest
http://link.springer.com/article/10.1038/s41467-020-14632-2Test

المؤلفون: Prashanth Prithviraj, Sagun Parakh, Elizabeth Liniker, M. Khou, Michael Millward, Paul Lorigan, Phillip Parente, Georgina V. Long, Jonathan Cebon, Stefan Diem, Samantha Bowyer, Grant A. McArthur, Benjamin Y. Kong, S. Ramanujam, Victoria Atkinson, Oliver Klein, James Larkin, Matteo S. Carlino, Miles C. Andrews, Alexander Guminski

المصدر: British Journal of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Phases of clinical research, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, ipilimumab, Adverse effect, Pneumonitis, nivolumab, business.industry, Melanoma, immune-mediated adverse event, Retrospective cohort study, medicine.disease, Surgery, 030104 developmental biology, 030220 oncology & carcinogenesis, Clinical Study, pembrolizumab, Nivolumab, business, medicine.drug, metastatic melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c10bbc468c875dc8fdb7ba9d41089227Test
http://europepmc.org/articles/PMC4865968Test